Artículos del autor

solaci

Chronic Ischemic cardiopathy

ESC 2020 | More Evidence on Colchicine for Chronic Ischemic Heart Disease

According to this new study, colchicine offers some benefit to patients with chronic ischemic heart disease. Similar...
solaci -
Other

ESC 2020 | 2020 Atrial Fibrillation Guidelines: News on Diagnosis, Classification, and Care

New guidelines for the diagnosis and treatment of atrial fibrillation (AF) were released at the 2020 European...
solaci -
Chronic Ischemic cardiopathy

ESC 2020 | Revascularization Strategies: Ventricular Dysfunction Might Tilt the Scales

Patients included in the ISCHEMIA trial who had a history of cardiac failure or ventricular function deterioration...
solaci -
Other

ESC 2020 | Dapagliflozin in Kidney Failure: The Drug Continues to Conquer Other Territories

The DAPA-CKD trial has shown dapagliflozin, a SGLT2 receptor inhibitor, improves function, and reduces cardiovascular events and...
solaci -
Chronic Ischemic cardiopathy

ESC 2020 | At Long Term, Diabetic Patients Benefit from Surgery

Data of this “real world” study have confirmed that diabetic patients with multivessel disease will benefit from...
solaci -
Chronic Ischemic cardiopathy

ESC 2020 | Post PCI Trimetazidine: No Adverse Events or Great Benefits

Trimetazidine in addition to optimal medical therapy in patients undergoing coronary PCI does not change events rate...
solaci -
Institutional News

SOLACI Webinar | Peripheral interventionism

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...
solaci -
Coronary disease

4° ProEducar Educational Meeting – Complex Coronary Intervention

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...
solaci -